Vitamin B3

Message
PROTECT FROM LIGHT.
POUR SERUM/PLASMA INTO AMBER TRANSPORT TUBE (PREFERRED) OR TRANSPORT TUBE WRAPPED IN ALUMINUM FOIL TO PROTECT FROM LIGHT.


Test Code
91029


Alias/See Also
LAB1109
VIT B3
NICOTINIC ACID
NICOTINAMIDE


CPT Codes
84591

Includes
Nicotinamide and Nicotinic Acid


Preferred Specimen
1 mL frozen serum collected in a red-top tube (no gel) - protected from light


Minimum Volume
0.5 mL


Other Acceptable Specimens
Frozen plasma collected in an EDTA (lavender-top) tube protected from light

Pour plasma into amber transport tube (preferred) or transport tube wrapped in aluminum foil to protect from light.


Instructions
Pour serum into amber transport tube (preferred) or transport tube wrapped in aluminum foil to protect from light.


Transport Container
Amber transport tube


Transport Temperature
Frozen


Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tube (SST)


Methodology
Chromatography/Mass Spectrometry

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule
10: 00 a. M. Tues, thurs, sat


Report Available
2-4 days


Reference Range
Nicotinamide
Nicotinamide is a metabolite of nicotinic acid. Due to the large variability in the metabolism of nicotinic acid, plasma concentrations of this metabolite are variable. In one study, fasting plasma concentrations were reported to be approximately 40 ng/mL. In another study it was reported that the administration of a single 1000 mg of extended-release tablet of nicotinic acid resulted in a mean peak nicotinamide concentration of 400 ng/mL between 5 and 10 hours post dose, decreasing to about 100 ng/mL by 16 hours post dose.

Nicotinic Acid
Due to the large variability in the metabolism of nicotinic acid, the dosing preparation used (immediate-release vs. extended release), and the mg doses used, the serum concentrations may range from less than 20 ng/mL to about 30,000 ng/mL. After oral administration of an immediate-release tablet, peak plasma concentrations occur in 4 to 5 hours. The plasma half-life of nicotinic acid is about one hour. In one study, fasting plasma concentrations were reported to be less than 20 ng/mL. In another study, it was reported that the administration of a single 1000 mg extended-release tablet resulted in mean nicotinic acid concentrations of less than 50 ng/mL.


Clinical Significance
Nicotinic acid occurs naturally in plants and animals and is also added to many foods as a vitamin supplement.


Performing Laboratory
Quest Diagnostics Nichols Institute
27027 Tourney Road
Valencia, CA 91355-5386




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.